CASTLE BIOSCIENCES, INC. Tax Withholding Paid on Stock Awards
CASTLE BIOSCIENCES, INC. (CSTL) reported Tax Withholding Paid on Stock Awards of $7.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $793.00K, a 34.63% increase year-over-year.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $6.60M, a 162.35% increase year-over-year.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $7.37M, a 15.50% increase year-over-year.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $1.19M, a 8.42% decline year-over-year.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $11.66M, a 33.04% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $8.76M, a 70.67% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $5.13M, a 204.15% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.69M, a 116.13% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $793.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $7.39M 10-Q · filed 2026-07-30 | $14.76M derived: sum of 3 quarters · filed 2026-07-30 | $15.94M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $6.60M 10-Q · filed 2026-05-06 | $13.97M derived: sum of 2 quarters · filed 2026-05-06 | $15.15M derived: sum of 3 quarters · filed 2026-05-06 | $15.74M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.55M derived: sum of 2 quarters · filed 2026-02-26 | $9.14M derived: sum of 3 quarters · filed 2026-07-30 | $11.66M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.77M derived: sum of 2 quarters · filed 2026-07-30 | $4.29M 10-Q · filed 2025-11-03 | $10.67M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.10M 10-Q · filed 2026-07-30 | $9.48M derived: sum of 3 quarters · filed 2026-07-30 | $10.78M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $2.52M 10-Q · filed 2026-05-06 | $8.89M derived: sum of 2 quarters · filed 2026-05-06 | $10.19M derived: sum of 3 quarters · filed 2026-05-06 | $10.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.67M derived: sum of 2 quarters · filed 2026-02-26 | $8.29M derived: sum of 3 quarters · filed 2026-02-26 | $8.76M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.91M derived: sum of 2 quarters · filed 2025-11-03 | $2.38M 10-Q · filed 2025-11-03 | $6.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $1.09M 10-Q · filed 2025-08-04 | $5.10M derived: sum of 3 quarters · filed 2026-02-26 | $5.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $474.00K 10-Q · filed 2025-05-05 | $4.49M derived: sum of 2 quarters · filed 2026-02-26 | $4.76M derived: sum of 3 quarters · filed 2026-02-26 | $5.29M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.29M derived: sum of 2 quarters · filed 2026-02-26 | $4.82M derived: sum of 3 quarters · filed 2026-02-26 | $5.13M 10-K · filed 2026-02-26 |
| 2023-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $805.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.12M 10-Q · filed 2024-11-04 | $2.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $848.00K 10-Q · filed 2024-08-05 | $2.40M derived: sum of 3 quarters · filed 2025-02-27 | $2.45M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $314.00K 10-Q · filed 2024-05-02 | $1.87M derived: sum of 2 quarters · filed 2025-02-27 | $1.91M derived: sum of 3 quarters · filed 2025-02-27 | $1.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.60M derived: sum of 2 quarters · filed 2025-02-27 | $1.63M derived: sum of 3 quarters · filed 2025-02-27 | $1.69M 10-K · filed 2025-02-27 |
| 2022-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $78.00K derived: sum of 2 quarters · filed 2023-11-02 | $134.00K 10-Q · filed 2023-11-02 | $915.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $88.00K 10-Q · filed 2023-08-02 | $869.00K derived: sum of 3 quarters · filed 2023-08-02 | $869.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $56.00K 10-Q · filed 2023-05-03 | $837.00K derived: sum of 2 quarters · filed 2023-05-03 | $837.00K derived: sum of 3 quarters · filed 2023-05-03 | $837.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $781.00K derived: sum of 2 quarters · filed 2023-02-28 | $781.00K derived: sum of 3 quarters · filed 2023-02-28 | $781.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |